Atara Biotherapeutics's total assets for Q4 2025 were $20.23M, a decrease of -32.92% from the previous quarter. ATRA total liabilities were $58.74M for the fiscal quarter, a -12.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.